Deadly zoonotic leishmaniasis raises tough questions about dog culling

09/13/2013 | Slate

Public health officials in Asia, Africa, South America and Europe have long debated the use of dog culling to curb the spread of leishmaniasis, a zoonotic pathogen that can manifest in humans as the deadly visceral leishmaniasis. Some 50,000 people worldwide die from the disease annually, and dogs are thought to be a key main reservoir for leishmaniasis. However, it's not clear that culling is effective, and although veterinarians in many affected countries are required to euthanize any dog that tests positive, the test is imperfect and asymptomatic dogs may not transmit disease. Although not a major concern in the U.S., the issue has sparked a difficult debate over the science and ethics of disease control in other nations.

View Full Article in:

Slate

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Medical Device Reimbursement Specialist - Regional
Alcon
Fort Worth , TX
Assistant General Counsel/Senior Corporate Counsel - Healthcare Law Group
Genentech
94080, CA
Clinical Trials Agreements Specialist (209955)
The Henry M. Jackson Foundation for the Advancement of Military Medicine Inc.
Rockville, MD
SAFETY, HEALTH, and ENVIRONMENTAL (SHE) REGIONAL SPECIALIST
Matheson Tri-Gas, Inc.
Newark, CA
MANAGER MEDICAL GAS COMPLIANCE AND SAFETY
Matheson Tri-Gas, Inc.
Houston, TX